CAS NO: | 206181-63-7 |
包装 | 价格(元) |
1mg | 电议 |
5mg | 电议 |
生物活性 | Ibritumomab tiuxetan is an immunoconjugate composed of the murine IgG1κ anti-CD20monoclonal antibody Ibritumomab that is covalently bound to the chelator Tiuxetan that permits the addition of the short-lived β-emitter radioisotope yttrium-90. Ibritumomab tiuxetan can be used for the research of non-Hodgkin's B-cell lymphomas[1][2]. |
IC50& Target | CD20sup>[1] |
体外研究 (In Vitro) | Ibritumomab 和 Tiuxetan 通过共价硫脲键结合。Tiuxetan 为两种放射性物质 Indium-111 (In-111) 和 Yttrium-90 (Y-90) 提供了一个限制螯合位点。 |
CAS 号 | 206181-63-7 |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |